Manulife (Manufacturers Life Insurance)
INDV icon

Manulife (Manufacturers Life Insurance)’s Indivior Pharmaceuticals INDV Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11M Buy
36,285
+121
+0.3% +$4K ﹤0.01% 1780
2025
Q4 		$1.3M Sell
36,164
-10,221
-22% -$312K ﹤0.01% 1725
2025
Q3 		$1.12M Sell
46,385
-1,212
-3% -$25.4K ﹤0.01% 1800
2025
Q2 		$702K Buy
47,597
+35,008
+278% +$408K ﹤0.01% 1988
2025
Q1 		$118K Sell
12,589
-1,666
-12% -$17.5K ﹤0.01% 2657
2024
Q4 		$183K Buy
14,255
+332
+2% +$3.42K ﹤0.01% 2659
2024
Q3 		$137K Sell
13,923
-59
-0.4% -$691 ﹤0.01% 2779
2024
Q2 		$219K Sell
13,982
-1,223
-8% -$22.1K ﹤0.01% 2567
2024
Q1 		$325K Buy
+15,205
New +$286K ﹤0.01% 2352

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s INDV Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Indivior Pharmaceuticals (INDV) stake by 0.33% in Q1 2026, buying an estimated $4K and bringing the position to 36,285 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Manulife (Manufacturers Life Insurance) first reported a position in INDV in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.3M in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 36,285 shares of Indivior Pharmaceuticals worth $1.11M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 121 Indivior Pharmaceuticals shares in Q1 2026, an estimated $4K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1780 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Indivior Pharmaceuticals position peaked at $1.3M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.